Acer Therapeutics Price on December 3, 2024
ACERDelisted Stock | USD 0.84 0.02 2.33% |
If you're considering investing in Acer Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acer Therapeutics stands at 0.84, as last reported on the 11th of December 2024, with the highest price reaching 0.86 and the lowest price hitting 0.83 during the day. We have found twenty-three technical indicators for Acer Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Acer Therapeutics' risk adjusted performance of (0.03), and Mean Deviation of 3.35 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Acer Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Acer |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
ACER |
Based on monthly moving average Acer Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acer Therapeutics by adding Acer Therapeutics to a well-diversified portfolio.
Related Headline
Lexaria Bioscience Headline on 3rd of December 2024
Insider Buying Richard Christopher Acquires 50,000 Shares of... by gurufocus.com
On December 3, 2024, Richard Christopher, the Chief Executive Officer of Lexaria Bioscience Corp, purchased 50,000 shares of the company, according to a SEC Fil
Acer Therapeutics Valuation on December 3, 2024
It is possible to determine the worth of Acer Therapeutics on a given historical date. On December 3, 2024 Acer was worth 0.86 at the beginning of the trading date compared to the closed value of 0.84. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Acer Therapeutics stock. Still, in general, we apply an absolute valuation method to find Acer Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acer Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Acer Therapeutics' related companies.
Open | High | Low | Close | Volume | |
12/11/2024 | 0.86 | 0.86 | 0.83 | 0.84 | 0.00 |
Backtest Acer Therapeutics | | | Acer Therapeutics History | | | Acer Therapeutics Valuation |
Acer Therapeutics Trading Date Momentum on December 3, 2024
Acer Therapeutics Fundamentals Correlations and Trends
By evaluating Acer Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Acer Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Acer financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Acer Therapeutics Stock history
Acer Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acer is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acer Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acer Therapeutics stock prices may prove useful in developing a viable investing in Acer Therapeutics
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts. Acer Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.
Acer Therapeutics Stock Technical Analysis
Acer Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Acer Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Acer Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Acer Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Acer Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acer Therapeutics shares will generate the highest return on investment. By undertsting and applying Acer Therapeutics stock market strength indicators, traders can identify Acer Therapeutics entry and exit signals to maximize returns
Acer Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Acer Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Acer Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acer to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.39) | |||
Total Risk Alpha | (0.96) | |||
Treynor Ratio | (0.16) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Acer Stock
If you are still planning to invest in Acer Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acer Therapeutics' history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |